Gastric protection by misoprostol against 1300 mg of aspirin
Authors:
- 1 February 1986
- journal article
- clinical trial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 31 (S2) , 137S-141S
Abstract
Misoprostol, a synthetic prostaglandin E1 analog is being evaluated in the treatment of peptic ulcer. It has been reported to have both antisecretory and cytoprotective properties. In this placebo-controlled, double-blind study, pretreatment with 200-μg doses of misoprostol was evaluated in the prevention of gastric injury caused by aspirin. Five oral doses of misoprostol or placebo were administered over 24 hr followed by a single oral 1296-mg dose of aspirin 30 min after the fifth dose of test agent. Two hours later the gastric mucosa was examined with a small-caliber fiberendoscope. Protection was defined as no more than 10 petechiae and no more than two hemorrhagic streaks in the gastric mucosa. Twenty of 30 (67%) subjects who received misoprostol was protected, whereas only one of 30 (3%) subjects receiving placebo was protected. The difference between the effects of misoprostol and placebo was highly significant (P<0.001). We concluded that five 200-μg doses of misoprostol given over 24 hr protects the gastric mucosa from the injurious effect of a single dose of aspirin.Keywords
This publication has 36 references indexed in Scilit:
- Upper gastrointestinal endoscopy in normal asymptomatic volunteersGastrointestinal Endoscopy, 1986
- Effect of synthetic prostaglandin E1 analog on aspirin-induced gastric bleeding and secretionDigestive Diseases and Sciences, 1983
- Comparison of prostaglandin E2 and ranitidine in prevention of gastric bleeding by aspirin in man.Gut, 1983
- Gastric adaptation occurs with aspirin administration in manDigestive Diseases and Sciences, 1983
- ENDOSCOPIC EVALUATION OF THE COMPARATIVE EFFECTS OF ACETYLSALICYCLIC ACID AND CHOLINE MAGNESIUM TRISALICYLATE ON HUMAN GASTRIC AND DUODENAL MUCOSARheumatology, 1983
- PREVENTION OF ASPIRIN-INDUCED DROP IN GASTRIC POTENTIAL DIFFERENCE WITH 16, 16-DIMETHYL-PROSTAGLANDIN E2The Lancet, 1981
- Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.Circulation, 1980
- COMPARISON OF THE EFFECTS OF REGULAR AND ENTERIC-COATED ASPIRIN ON GASTRODUODENAL MUCOSA OF MANThe Lancet, 1980
- Acute effect of systemic aspirin on gastric mucosa in manDigestive Diseases and Sciences, 1980
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978